TABLE 1.
Amino acid group | Feeding group | Arginine infusion rate, μmol⋅kg−1⋅h−1 |
|||||
Saline2 | 50 | 100 | 200 | 400 | 800 | ||
μmol/L | |||||||
Arginine | TPN3 | 66 ± 7a | 124 ± 25b | 186 ± 35b | 283 ± 37c | 336 ± 105c | 404 ± 87c |
PEN3 | 119 ± 6a | nd4 | 252 ± 21b | 385 ± 30c | 685 ± 43d | 1394 ± 38e | |
Ornithine5 | TPN3 | 25 ± 3a | 34 ± 7a | 47 ± 7b | 71 ± 10bc | 82 ± 20bc | 113 ± 25c |
PEN3 | 51 ± 5a | nd | 75 ± 7b | 108 ± 7bc | 178 ± 42c | 252 ± 12d | |
Citrulline5 | TPN | 113 ± 17 | 118 ± 17 | 105 ± 8 | 125 ± 12 | 113 ± 17 | 111 ± 14 |
PEN | 142 ± 4 | nd | 152 ± 9 | 134 ± 9 | 153 ± 8 | 165 ± 12 | |
Proline5 | TPN | 640 ± 100 | 574 ± 65 | 556 ± 37 | 610 ± 52 | 596 ± 61 | 677 ± 90 |
PEN | 493 ± 14b | nd | 352 ± 9a | 397 ± 33a | 387 ± 26a | 389 ± 25a | |
Glutamine5 | TPN | 811 ± 125 | 619 ± 61 | 665 ± 42 | 645 ± 81 | 666 ± 92 | 628 ± 74 |
PEN | 447 ± 45 | nd | 392 ± 49 | 396 ± 45 | 410 ± 53 | 341 ± 34 | |
Glutamate5 | TPN | 353 ± 82 | 302 ± 36 | 256 ± 39 | 334 ± 45 | 295 ± 35 | 310 ± 31 |
PEN | 234 ± 7 | nd | 188 ± 12 | 198 ± 19 | 190 ± 17 | 194 ± 16 | |
Threonine | TPN | 1161 ± 333 | 1151 ± 125 | 1188 ± 152 | 1196 ± 180 | 1121 ± 169 | 936 ± 198 |
PEN | 1089 ± 32 | nd | 989 ± 67 | 905 ± 87 | 986 ± 85 | 937 ± 82 | |
Lysine | TPN | 295 ± 85 | 318 ± 46 | 307 ± 33 | 305 ± 43 | 254 ± 41 | 261 ± 48 |
PEN6 | 365 ± 10 | nd | 273 ± 27 | 237 ± 11 | 251 ± 22 | 250 ± 10 |
Means ± SEM, = 4–6 (TPN) or 9 (PEN) unless otherwise noted. Means in a row with superscripts without a common letter differ, P < 0.05.
Values for saline represent overall mean from each arginine dose level, = 24 (TPN) or 36 (PEN) unless otherwise noted.
Significant effect of treatment (TPN vs. PEN), < 0.05
nd, Not determined.
Significant arginine dose effect, linear < 0.01.
Significant arginine dose effect, linear < 0.05.